Summary
There is evidence that the immune system may play a role in the pathogenesis of autonomic neuropathy in Type 1 (insulin-dependent) diabetes mellitus. In the present study, we investigated the presence of autoantibodies to sympathetic and parasympathetic nervous structures and their correlation with other conventional autoantibodies in well-characterised diabetic populations, with or without diabetic neuropathy, and normal subjects. An indirect immunofluorescent complement-fixation technique was used, with monkey adrenal gland, rabbit cervical ganglia and vagus nerve as substrates. Of the patients with symptomatic autonomic neuropathy 33% were positive for at least one autoantibody (20% anti-sympathetic ganglia, 10% anti-vagus nerve and 13% anti-adrenal medulla). The frequency of having one or more antibodies to nervous tissues and the prevalence of anti-cervical ganglia antibodies were significantly higher in the neuropathic patients than in the diabetic control subjects with disease of similar duration and in the normal subjects (p<0.05). Of the patients without complications with diabetes of shorter duration 33% were also positive for at least one autoantibody (13% anti-ganglia, 13% anti-vagus nerve and 13% anti-adrenal medulla). No correlation was found with other tissue autoantibodies, including islet cell antibodies. Our data indicate that nervous tissue autoantibodies are associated with symptomatic autonomic neuropathy. Anti-sympathetic ganglia and anti-vagus nerve antibodies seem to be more disease-specific. Patients with diabetes of shorter duration who were positive for these autoantibodies may represent pre-neuropathic patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Duchen LW, Anjorin A, Watkins PJ, Mackay JD (1980) Pathology of autonomic neuropathy in diabetes mellitus. Ann Int Med 92: 301–303
Gilbey SG, Hussain MJ, Watkins PJ, Vergani D (1988) Cell-mediated immunity and symptomatic diabetic autonomic neuropathy. Diabetic Med 5: 845–848.
Guy RJC, Richards F, Edmonds ME, Watkins PJ (1984) Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause? Br Med J 289: 343–345
Dernouchamps JP, Vaerman JP, Michiels J, Masson PL (1977) Immune complexes in the aqueous humor and serum. Am J Ophthalmol 84: 24–31
Gilbey SG, Guy RJC, Vergani D, Watkins PJ (1986) Diabetes and autonomic neuropathy: an immunological association? Diabetic Med 3: 241–245
Rabinowe SL (1990) Immunology of diabetic and polyglandular neuropathy. Diab Metab Rev 6: 169–188
Sundkvist G, Lind P, Bergstrom B, Lilja B, Rabinowe SL (1991) Autonomic nerve antibodies and autonomic nerve function in type 1 and type 2 diabetic patients. J Intern Med 229: 505–510
Rabinowe SL, Brown FM, Watts M, Smith AM (1990) Complement-fixing antibodies to sympathetic and parasympathetic tissues in IDDM. Diabetes Care 13: 1084–1088
Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285: 916–919
Millward BA, Hussain MJ, Peakman M, Pyke DA, Leslie RDG, Vergani D (1988) Characterization of islet cell antibodies in insulin-dependent diabetes: evidence for IgG1 subclass restriction and polyclonality. Clin Exp Immunol 71: 353–356
Brown FM, Kamalesh M, Sesh Adri MN, Rabinowe SL (1988) Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM. Diabetes Care 11: 30–33
Rabinowe SL, Brown FM, Watts M, Kadrofske MM, Vinik AI (1989) Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM. Diabetes Care 12: 1–6
Drell DW, Notkins AL (1987) Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132–143
Lendrum R, Walker GJ, Cudworth AG et al. (1975) Islet-cell antibodies in diabetes mellitus. Lancet II: 1273–1276
Peakman M, Hussain MJ, Cundy T, Vergani D (1989) Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves disease in long-term remission. J Clin Lab Immunol 30: 1–5
Brown FM, Vinik AI, Ganda OP, Adri MNS, Rabinowe SL (1989) Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type 1 diabetes mellitus. Horm Metabol Res 21: 434–437
Baekkeskov S, Aanstoot HJ, Christgau S et al. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA synthesizing enzyme glutamic acid decarboxylase. Nature (Lond) 347: 151–156
Kaufman DL, Erlander MG, Salzer MC et al. (1992) Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 89: 283–292
Goncavales E, Brown FM, Rabinowe SL (1990) Pilot study of immunosuppressive therapy in diabetic neuropathy associated with neuronal autoantibodies. Diabetes 39 [Suppl 1]: 778 (Abstract)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zanone, M.M., Peakman, M., Purewal, T. et al. Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36, 564–569 (1993). https://doi.org/10.1007/BF02743275
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02743275